222 related articles for article (PubMed ID: 9420208)
1. Fusion activity of transmembrane and cytoplasmic domain chimeras of the influenza virus glycoprotein hemagglutinin.
Schroth-Diez B; Ponimaskin E; Reverey H; Schmidt MF; Herrmann A
J Virol; 1998 Jan; 72(1):133-41. PubMed ID: 9420208
[TBL] [Abstract][Full Text] [Related]
2. Modification of the cytoplasmic domain of influenza virus hemagglutinin affects enlargement of the fusion pore.
Kozerski C; Ponimaskin E; Schroth-Diez B; Schmidt MF; Herrmann A
J Virol; 2000 Aug; 74(16):7529-37. PubMed ID: 10906206
[TBL] [Abstract][Full Text] [Related]
3. The role of the cytoplasmic tail region of influenza virus hemagglutinin in formation and growth of fusion pores.
Melikyan GB; Jin H; Lamb RA; Cohen FS
Virology; 1997 Aug; 235(1):118-28. PubMed ID: 9300043
[TBL] [Abstract][Full Text] [Related]
4. Domain-structure of cytoplasmic border region is main determinant for palmitoylation of influenza virus hemagglutinin (H7).
Ponimaskin E; Schmidt MF
Virology; 1998 Sep; 249(2):325-35. PubMed ID: 9791024
[TBL] [Abstract][Full Text] [Related]
5. Murine leukemia virus R Peptide inhibits influenza virus hemagglutinin-induced membrane fusion.
Li M; Li ZN; Yao Q; Yang C; Steinhauer DA; Compans RW
J Virol; 2006 Jun; 80(12):6106-14. PubMed ID: 16731949
[TBL] [Abstract][Full Text] [Related]
6. Amino acid sequence requirements of the transmembrane and cytoplasmic domains of influenza virus hemagglutinin for viable membrane fusion.
Melikyan GB; Lin S; Roth MG; Cohen FS
Mol Biol Cell; 1999 Jun; 10(6):1821-36. PubMed ID: 10359599
[TBL] [Abstract][Full Text] [Related]
7. Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion.
Takeda M; Leser GP; Russell CJ; Lamb RA
Proc Natl Acad Sci U S A; 2003 Dec; 100(25):14610-7. PubMed ID: 14561897
[TBL] [Abstract][Full Text] [Related]
8. Meta-stability of the hemifusion intermediate induced by glycosylphosphatidylinositol-anchored influenza hemagglutinin.
Nüssler F; Clague MJ; Herrmann A
Biophys J; 1997 Nov; 73(5):2280-91. PubMed ID: 9370425
[TBL] [Abstract][Full Text] [Related]
9. Acylation of the influenza hemagglutinin modulates fusion activity.
Fischer C; Schroth-Diez B; Herrmann A; Garten W; Klenk HD
Virology; 1998 Sep; 248(2):284-94. PubMed ID: 9721237
[TBL] [Abstract][Full Text] [Related]
10. Targeted delivery of human neurofibromin and c-Raf-1 mutants to the cytoplasmic membrane by use of the influenza virus hemagglutinin.
Nur-E-Kamal MS; Reverey H; Ponimaskin E; Schroth-Diez B; Herrmann A; Schmidt MF
Biochim Biophys Acta; 1997 Apr; 1338(2):233-43. PubMed ID: 9128141
[TBL] [Abstract][Full Text] [Related]
11. The 1-127 HA2 construct of influenza virus hemagglutinin induces cell-cell hemifusion.
Leikina E; LeDuc DL; Macosko JC; Epand R; Epand R; Shin YK; Chernomordik LV
Biochemistry; 2001 Jul; 40(28):8378-86. PubMed ID: 11444985
[TBL] [Abstract][Full Text] [Related]
12. Fatty acids on the A/USSR/77 influenza virus hemagglutinin facilitate the transition from hemifusion to fusion pore formation.
Sakai T; Ohuchi R; Ohuchi M
J Virol; 2002 May; 76(9):4603-11. PubMed ID: 11932425
[TBL] [Abstract][Full Text] [Related]
13. Influence of acylation sites of influenza B virus hemagglutinin on fusion pore formation and dilation.
Ujike M; Nakajima K; Nobusawa E
J Virol; 2004 Nov; 78(21):11536-43. PubMed ID: 15479794
[TBL] [Abstract][Full Text] [Related]
14. Endocytosis of chimeric influenza virus hemagglutinin proteins that lack a cytoplasmic recognition feature for coated pits.
Lazarovits J; Naim HY; Rodriguez AC; Wang RH; Fire E; Bird C; Henis YI; Roth MG
J Cell Biol; 1996 Jul; 134(2):339-48. PubMed ID: 8707820
[TBL] [Abstract][Full Text] [Related]
15. Inner but not outer membrane leaflets control the transition from glycosylphosphatidylinositol-anchored influenza hemagglutinin-induced hemifusion to full fusion.
Melikyan GB; Brener SA; Ok DC; Cohen FS
J Cell Biol; 1997 Mar; 136(5):995-1005. PubMed ID: 9060465
[TBL] [Abstract][Full Text] [Related]
16. Structural and functional specificity of Influenza virus haemagglutinin and paramyxovirus fusion protein anchoring peptides.
Kordyukova L
Virus Res; 2017 Jan; 227():183-199. PubMed ID: 27773768
[TBL] [Abstract][Full Text] [Related]
17. A point mutation at the C terminus of the cytoplasmic domain of influenza B virus haemagglutinin inhibits syncytium formation.
Ujike M; Nakajima K; Nobusawa E
J Gen Virol; 2006 Jun; 87(Pt 6):1669-1676. PubMed ID: 16690932
[TBL] [Abstract][Full Text] [Related]
18. The membrane-proximal domain of vesicular stomatitis virus G protein functions as a membrane fusion potentiator and can induce hemifusion.
Jeetendra E; Robison CS; Albritton LM; Whitt MA
J Virol; 2002 Dec; 76(23):12300-11. PubMed ID: 12414970
[TBL] [Abstract][Full Text] [Related]
19. Evolution of intermediates of influenza virus hemagglutinin-mediated fusion revealed by kinetic measurements of pore formation.
Markosyan RM; Melikyan GB; Cohen FS
Biophys J; 2001 Feb; 80(2):812-21. PubMed ID: 11159448
[TBL] [Abstract][Full Text] [Related]
20. The lipid-anchored ectodomain of influenza virus hemagglutinin (GPI-HA) is capable of inducing nonenlarging fusion pores.
Markosyan RM; Cohen FS; Melikyan GB
Mol Biol Cell; 2000 Apr; 11(4):1143-52. PubMed ID: 10749920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
